Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

p53 and chemosensitivity.

C G Ferreira¹, C Tolis, G Giaccone

¹Department of Medical Oncology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands.

Annals of Oncology : Official Journal of the European Society for Medical Oncology

|November 26, 1999

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

AAV-Driven miR-146a Promotes Neurite Outgrowth and Axonal Regeneration in Cortical Neurons.

Journal of neurochemistry·2026

Same author

A novel phenotype of sporadic Creutzfeldt-Jakob disease.

BMJ case reports·2025

Same author

Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Same author

Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Same author

Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials.

ESMO open·2021

Same author

Early and long-term cognitive features in sporadic Creutzfeldt-Jakob disease.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2021

Same journal

The ethical obligation to use positive trial results.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Same journal

Lorlatinib: The Crown Jewel of ALK Inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Same journal

TROP2-Directed Antibody Drug Conjugates: New First-Line Treatment for All Patients with Advanced Triple-Negative Breast Cancer?

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Same journal

When artificial intelligence learns to abstain: towards clinically responsible diagnostic support in liver pathology.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Same journal

PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block?

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Same journal

Refining decision making in hormone receptor-positive early-stage breast cancer: moving from static to dynamic.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

See all related articles

The tumor suppressor protein p53 has a dual role in chemotherapy response. It can promote cancer cell death (apoptosis) or DNA repair and survival, impacting treatment effectiveness.

Area of Science:

Oncology
Molecular Biology
Genetics

Background:

Most prevalent solid tumors exhibit resistance to cytotoxic chemotherapy.
The tumor suppressor protein p53 is crucial for apoptosis, a key mechanism in chemotherapy-induced cancer cell death.
p53 also mediates cell cycle arrest and DNA repair, potentially reducing chemotherapy sensitivity.

Purpose of the Study:

To review the multifaceted roles of p53 in mediating chemosensitivity.
To discuss preclinical and clinical data linking p53 status to chemotherapy response.
To identify potential limitations in studies investigating p53 and chemosensitivity.

Main Methods:

Comprehensive review of peer-reviewed literature.
Analysis of preclinical data on p53 and chemosensitivity.

Related Experiment Videos

Discussion of clinical findings regarding p53 and treatment outcomes.

Main Results:

p53 exhibits a dual function: promoting apoptosis or facilitating DNA repair and cell survival.
Contradictory results in existing studies may stem from methodological limitations.
Understanding p53's complex role is vital for predicting and improving chemotherapy efficacy.

Conclusions:

The p53 protein's role in chemosensitivity is complex and context-dependent.
Further research is needed to reconcile conflicting data and elucidate p53's precise impact on treatment response.
Targeting p53 pathways may offer novel strategies to enhance cancer therapy outcomes.